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INTRODUCTION
Pharmaceutical sales promotion and prescribing activities have had a 
symbiotic relationship for most part and did provide beneits to the 
patients. Ethical pharmaceutical sales promotion results in increased 
prescribers’ drug knowledge and evidence base. his technique empowers 
the prescriber to prescribe a drug with a better understanding. However, 
the dark side of this relationship can result in patient harm as it has also 
been seen as a marketing prospect for the pharmaceuticals and promotes 
tendency to indulge in irrational prescribing by prescribers for the sake 
of inducements. It was reported in Turkey where the general practitioners 
GPs used information provided by the pharmaceuticals for prescribing 
which inluenced their decision making.1
he whereabouts of this relationship go far beyond the pharmaceutical 
sales representatives and prescribers union. García-Alonso and García-
Mariñoso 2008 studied the strategic relationship between the pharma-
ceuticals and reimbursement agencies in which they observed tendency 
of agencies to reimbursement high priced drugs which hints at the 
hidden relationship.2 Similarly Nguyen NY and Bero L 2013 revealed 
inadequate and non transparent policies regarding drug selection and 
exposed the vulnerability of drug reimbursement programs to pharma-
ceutical irm’s inluence.3
To address the issue, a number of guidelines and legislations were carried 
out in diferent parts of the globe. Gustafsson LL et al 2011 carried out 
a 10 year study to evaluate the efectiveness of a specially formulated 
essential drugs recommendation list which was of beneit to the prescri-
bers as they found it trustworthy. he technique promoted rational 
prescribing and use of the medications.4
In Asia, particularly in South Korea reforms were made in the anti-rebate 
law speciically to address the issue of unethical pharmaceutical marketing 
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ABSTRACT
Introduction: Pakistan is the 6th most populous country in the world and 
has an enormous potential for an ever increasing drug market. The health 
care system is highly prone to unethical drug prescribing practices. In 
addition, there is a huge tendency of pharmaceutical irms to indulge in 
unethical drug promotional practices by means of inducements and other 
beneits through their medical sales representatives (MSRs). On the other 
hand, the prescribers are also reported to be demanding inducements 
from these companies in return to write higher number of prescription. 
This study investigated the ground realities of drug promotion and prescribing 
practices in Pakistan. Materials and Methods: A cross sectional study 
was conducted for a period of 8 months in which 472 physicians and 609 
medical sales representatives of Pakistan selected through prospective 
sampling were interviewed on a validated, structured questionnaire. The 
responses of the target groups were then analyzed for association be-
tween variables by Chi–square test (p<0.05) and cross tabulation through 
SPSS, version 20. Results: Majority of practitioners (83.2%) expected 
both, good communication skills and knowledge from MSRs and at the 
same time nearly half (53%) of prescribers demanded CME and almost 
a third proportion (36%) demanded gifts, incentives and inducements 
from MSRs. Replying to same question, MSRs disagreed with prescrib-
ers and believed that around (~70%) of prescribers ask for inducements 
with a high percentage i.e. (~64%) among them demanding unethical 
inducements like excessive free samples, gifts, leisure trips and cars. 
Majority of physicians (92%) have consensus that the multinational phar-
maceutical irms have deined promotional practices while the national 
pharmaceutical companies (~73%) are mainly involved in unethical prac-
tices of drug marketing. Conclusion: Majority of national pharmaceu-
ticals as well as prescribers were involved in unethical drug promotion 
and prescribing respectively. There is a need of curbing the unethical drug 
promotion and prescribing and formidable policies governing this issue 
are required to be implemented by the concerned regulatory authorities 
to avoid unnecessary harm to the patient’s life and pocket. Strength and 
weakness of study: The study explored the drug promotion and prescribing 
practices for the irst time in a developing country however, due to sensitivity 
of the topic a number of respondents hesitated to participate.
Key words: Drug, Drug detailing, CME, Medical sales representative, 
Physicians, Pakistan.
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and sales promotion activities to level criminal charges against prescribers 
and pharmacists involved in such practices.5
However, the story of Pakistan is quite diferent. he population of Pakistan 
is about 184,350,000 making it the world’s 6th most populous country.6,7 
here is a huge pharmaceutical market in the country.8 he growth of 
pharmaceutical industry in the last decade was substantial and the value 
of sales of medicine was 10th highest in Asia with a value of US $2.34 
billion in 2012.9,10 he prescribers in the country have the tendency to 
indulge in irrational prescribing. Although, not all prescribers indulge 
in irrational prescribing but a number of studies carried out in diferent 
parts of the country have reported the issue of irrational prescribing by 
majority of the prescribers.11,12 he regulations regarding health practices 
contain loop holes as many of the prescription-only-medicines POM are 
freely available over the counter OTC.8
he standard of pharmacies is below parity and sometimes absence of 
qualiied pharmacist increase the risk of patient harm. here is an absolute 
need to raise the standards of community pharmacies by employing 
qualiied pharmacist and increase the knowledge of drug sellers.13,14 
Although, the practice of pharmacy is developing switly in the country 
and ater the starting of Doctor of Pharmacy program in 2003 by 
Government of Pakistan, the pharmacists have shown conidence in 
tackling these issues but it is still early for them to fully get involve in 
patient care and play their role.15 Moreover, the pharmacists also face 
diiculties from prescribers and other healthcare professionals in direct 
patient care as the prescribers and other healthcare professionals feel 
insecurity and interference in their job making them feel uncomfortable.16 
he ield is therefore let empty for the prescribers to exercise their 
authority and freely prescribe whatever medication they deem it for 
the patient. his scenario puts prescribers in a commanding position 
in health care system and subsequently, they are viewed as marketing 
prospects for pharmaceuticals and as the ones having the potential to 
increase the pharmaceutical sales.
he medical sales representatives or medical representatives MSRs are 
irst–line force of a pharmaceutical organization and play an important 
role in nurturing and establishing this relationship. his relationship 
between pharmaceuticals and prescribers is symbiotic and in developed 
countries the pharmaceutical organization promotes ethical marketing 
strategies and academic detailing to promote rational prescribing and 
sales of their medicines. he prescribers also beneit from this as their 
knowledge is increased empowering them to prescribe rationally.17 
However, in a developing country like Pakistan where enforcement 
of health regulations and role of pharmacist are in embryonic stages, 
pharma ceuticals and prescribers are oten free to act as they deem it 
with the target of increasing sales prospects. Although a code of eth-
ics of Pakistan Medical and Dental Council exists and clause 40, 51 to 
54 of the said code speciically deal with the subject.18,19 Despite this, 
the unethical drug promotion and prescribing is carried out in the 
country.20
he prescribers demand favors and pharmaceuticals companies usually 
provide them in return for increase number of prescription containing 
their products.8 Orlowski and Wateskain 1992 reported the use of paid 
holidays trips by pharmaceuticals to prescribers in return for increase 
number of prescription.22 Khan in 2004 reported the various types of 
inducements pharmaceuticals provided the prescribers which included 
continuous medical education CME which is beneicial, ethical and 
promotes rational prescribing such as conferences, symposiums and 
medical books. Also, unethical inducements such as drug samples, paid 
holiday trips, lunch, and expensive luxury gits such as furniture for clin-
ics, air conditions, laptops, etc.21 he latest trend observed in ofering 
drug promotion incentives by the pharmaceuticals in Pakistan is to pro-
vide down payment to prescriber for a new car in return for prescribing a 
certain amount of prescriptions per month containing the pharmaceuti-
cal irm’s brand.21-24 Some of the physicians are only interested in the in-
ducements and fail to recognize the inaccurate statements of the medical 
sales representatives.25 he phenomenon was also investigated in Turkey 
by Dilaver etal and it was reported that the drug detailing and promotion 
is an ethical issue.26
In the regional context similar studies in Saudi Arabia and India revealed 
concerns in the public opinion on the growing prescriber-pharmaceuti-
cal irm relationship.27,28 he purpose of this study was to investigate the 
situation prevailing in Pakistan regarding drug promotion and prescrib-
ing practices.
MATERIALS AND METHODS
A quantitative cross sectional study for the period of 8 months was 
conducted among the prescribers and medical sales representatives 
MSRs of Pakistan in which they were interviewed based on a survey 
questionnaire. he interview included general questions related to their 
demographics, expectation and working experiences with each other 
and was mainly chosen over person illing of questionnaire by respondent 
to facilitate their busy schedule. 
Duration of the study
he research was performed for a period of 8 months from March 2014 
to October 2014. 
Study instrument
he study instrument initially consisted of a survey questionnaire which 
was slightly modiied to interview questionnaire ater piloting and vali-
dation by a team of experts prior to data collection. 
Piloting and validation procedure
A pilot study was conducted on 38 prescribers and 22 medical sales 
representatives MSRs by simply handing the survey questionnaire and 
collecting it at time of their convenience. his mode of data collection 
reported the tendency of few prescribers to turn down few questions of 
the survey questionnaire. he cause was then investigated and identiied 
as prescriber’s time consumption during illing of responses and some of 
the open ended questions in the questionnaire.
he study instrument was then modiied and the questionnaire response 
illing was facilitated by interviews which were conducted by volunteers who 
were coordinating the research. It was done to facilitate the data gathering 
keeping the respondents’ busy schedule in view. he open ended ques-
tions were modiied to close ended to minimize the chance of avoiding 
questions by respondents.
he interviews were solely based on the questions from the research 
instrument which were mostly close ended and the respondents’ answers 
were marked on the interview questionnaire by the research coordinator. 
he role of the research coordinator was solely to facilitate the data gath-
ering. It took 7-8 min to conduct the interview and ill in the response 
on the questionnaire.
he study instrument was again subjected to pilot study on 16 prescribers 
and 9 MSRs and thus validated. he results of the pilot study were not 
included in the main data.
Ethical Approval
he study was ethically approved by the Institutional Review Board of 
Cliton Hospital in Karachi, Pakistan (Ethical Approval # CH-0231-14).
Informed consent
An informed written consent was obtained from the participants before 
recording their responses.
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Target population and sampling
he population for research included prescribers and sales representa-
tives from Pakistan. 502 prescribers were selected working in diferent 
public and private hospitals and 672 medical sales representatives MSRs 
associated with general medicines and specialized medicines group 
across Pakistan respectively. he selection of the participants was based 
on probability sampling.
he questionnaire based interviews were conducted in person, out of 
the total 502 physicians selected, 82 refused to consent leaving behind 
only 420 physicians. 63 medical sales representatives out of the total 672 
refused to undergo interview, as a result 609 sales representatives were 
available. 
Inclusion/ exclusion criteria
Only prescribers and medical sales representatives MSRs were included 
in the study. hose prescribers and MSRs who did not consent were also 
let out. Incomplete responses from the target population were also ex-
cluded.
Data analysis
he target group was then questioned and their response was analyzed 
using Statistical Package for Social Sciences (SPSS, version 20). he re-
sults of each response in the interview were reported as percentage (%) 
and and in some cases as Standard Deviation (SD). Also, results were 
also reported as Sample (N) in tables. he Chi–square X2 test and cross 
tabulation was used to test the association between the demographic 
variables of respondents and their expectations. Statistical signiicance 
was accepted at P value of <0.05 i.e. (P value less than 0.05).
Conceptual framework
he study hypothesized that the drug promotion and prescribing practices 
are ethical. he hypothesis was tested statistically using chi square X2 test.
RESULTS
Out of the total 502 physicians selected, 82 refused to consent leaving 
behind only 420 physicians. 63 medical sales representatives out of the 
total 672 refused to undergo interview, as a result 609 sales representa-
tives were available for their response to be documented. he results of 
the study are reported as:
• Demographic information
• Social information
• Personal experiences of MSRs 
• Personal experiences of prescribers
• Association of demographic and social information
Demographic information
Physicians
he results reveal that the majority of the physicians (69.5%) were prac-
ticing in the private healthcare settings while the rest (30.5%) were 
associated with the public health care facilities (0.46 SD). he medical 
sales representatives for most part (59%) were seen to be associated with 
the national pharmaceutical companies while the rest (41%) were associ-
ated with multinational pharmaceutical irms. (0.39 SD).
Medical Sales Representatives MSRs
It was observed that almost half of the medical sales representatives (46.6%) 
had a work experience of 5 to 10 years while a third (33.6%) had more 
than 10 years. Few were new to this ield (19.8%) having experience of 
less than 5 years (0.72 SD). he prescribers in this survey were observed 
to be mostly (56.1 %) new with an experience of less than 5 years, a 
signiicant proportion of prescribers (36.9%) were seen having experi-
ence between 5 to 10 years and few had been practicing for over 10 years. 
(7%) (0.5 SD). he summary of demographic information is tabulated 
in Table 1.
Social information
Physicians
When the prescribers were asked about their expectations from a medical 
sales representative they expected good communication skills of drug 
detailing (12%) and evidence base behind the drug being promoted (4.8%) 
while the majority believed (83.2%) that both the qualities should be ex-
hibited by medical sales representatives. When they were asked about 
their demands from medical sales representatives, they were initially 
skeptical about the response and only (36%) demanded gits, incentives 
as inducements while the majority (52.7%) demanded continued medical 
education CME as inducements making up a majority (88.7%) who 
demanded inducements. he rest (11.3%) did not demand anything 
and prescribed drug solely on knowledge. he majority of the prescribers 
(98.2%) responded that the MSRs demanded their brand to be prescribed 
in return however a minor segment (1%) wanted the competitor’s brand 
not to be prescribed. Almost negligible percentage (0.8%) did not 
demand anything.
Medical Sales Representatives MSRs
On the other hand majority of medical sales representatives MSRs (67.2%) 
had a favorable opinion regarding ethical practices by physicians while 
the rest (38.2%) had diferent view. 
Contrastingly, according to the medical sales representatives, the mass 
(63.8%) demanded unethical inducements such as expensive gits, 
samples, leisure trips and other luxury while the rest (26.2%) were in 
favor of ethical inducements such as books, CME and conferences. he 
rest (10%) did not demand anything.
Out of all of the unethical demands of prescribers from the MSRs (63.8%) 
considering it as a whole (63.8%=100%), it was reported by the MSRs 
that almost all prescribers demanded the samples of the medicines being 
promoted, apart from this the prescribers demanded a combination of 
inducements, majority (67%) demanded leisure trips and the rest (13%) 
demanded furniture for their clinics and expensive gits such as cars 
(13%), few (7%) demanded air conditions and liquid crystal display 
(LCDs) television, renovation of their clinical settings along with samples 
of the drug being promoted.
he sales representatives responded in majority (99.1%) that they 
demand the prescribers to prescribe their brand while almost negligible 
percentage of MSR (0.5%) wanted prescriber not to prescribe competitor’s 
brand and very few (0.4%) demanded nothing. he social information is 
presented in Table 2.
Personal experiences
MSRs with Prescribers
When the MSRs were questioned about their actual personal experience 
with prescribers, masses responded (70.2%) indicating the tendency of 
prescribers to increase drug prescribing and subsequently drug sales for 
inducements. However, a third (29.8%) abstained from answering. he 
study revealed qualitatively that the ground reality wears an awful look 
as the prescribers ignore patient health safety for the sake of increasing 
the drug sales and hence indulge in unethical practice reported by MSRs.
Prescribers with MSRs
When the prescribers were asked about their personal experience with 
the prescribing practice, the majority (92%) pointed out the loopholes 
with respect to pharmaceuticals irms and their policy regarding the 
issue, however a fraction (8%) did not respond to this question. Further-
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Table 1: Summary of demographic information
Demographics Percentage % Sample N
Target population
Prescribers 40.8% 420
Medical Sales Representatives MSRs 59.2% 609
Total 100% 1029
Work place of prescribers
Public 30.5% 128
Private 69.5% 292
Total 100% 420
Work place of MSRs
National Pharmaceutical Firms 59% 359
Multinational Pharmaceutical Firms 41% 250
Total 100% 609
Work experience of prescribers
Less than 5 years 56.1% 236
Between 5 years to 10 years 36.9% 155
More than 10 years 7% 29
Total 100 % 420
Work experience of MSRs
Less than 5 years 19.8% 120
Between 5 years to 10 years 46.6% 284
More than 10 years 33.6% 205
Total 100% 609
more, the qualitative aspect of the study reported that the multinational 
pharmaceutical irms have deined policies on the issue of drug promotion 
and use ethical inducements for most part to promote their brand and 
many national pharmaceutical irms are lacking such policies. hey were 
observed to be associated with unethical inducements as reported by 
those prescribers who initially responded to the question. he personal 
experience of MSRs and prescribers is tabulated in Table 3.
Association of demographic and social information
he association of demographic and social information was analyzed by 
chi square X2 test for association. he demographic variables were tested 
for any association with social variables and statistical signiicance was 
accepted at P value <0.05. he study reported that demographic variable 
of work experience of MSRs was associated with physician’s expectation 
of good communication skills (P value <0.05). he statistical indings 
interprets that the prescribers expectation is high from a relatively young 
MSR and the expectation level usually drops as the experience increase. 
Furthermore, the work experience of prescribers were seen to be associated 
with their demand of unethical inducements (P value <0.05). Statically, 
the study reported a surge in unethical demands with increasing work 
experience. 
In addition, the work place of prescriber was associated with their 
demand of CME (P value <0.05). his statistical inding interprets that 
the prescribers who were involved in private health care setting were 
more career oriented and well focused towards learning medical knowledge. 
DISCUSSION
his research study was conducted for 8 months in diferent parts of 
Pakistan in order to obtain a more general view of the various aspects 
of drug marketing and promotional practices prevailing in the country. 
For this almost 420 physicians and 609 medical sales representatives 
(MSRs) who are the sales force for any pharmaceutical company were 
interviewed on a structured and validated pattern. 
In this study a substantial proportion of medical sales representatives 
(MSRs) were found to have more than 10 years of experience in sales 
(33.6%), while the majority (46.6%) of the MSRs interviewed, consisted 
of those who were in the ield for more than 5 years but less than 10 years. 
his let only ~20% of MSR who were classiied as relatively young 
having less than 5 years of experience. his scenario could be attributed 
to the fact that ater certain years of experience in sales, usually 5-8 years, 
the MSRs are promoted to higher managerial positions depending upon 
their performance, skills, company policies and vacancies. On the other 
hand the physicians/prescribers inducted in this study mainly comprised 
of relatively young practitioners (56.1%). However, there was a sizeable 
proportion (36.9%) of physicians who had experience of 5-10 years in the 
ield. Only a small fraction constituted of senior prescribers (7%) who 
had experience of more than 10 years in their respective specialty. his 
scenario also relects the dilemma of brain drain of several professionals 
including medical doctors from Pakistan in the recent decades who go 
to Middle Eastern countries, US, and UK etc. to settle permanently with 
families.29,31 he remaining consulting specialists prefer to work on either 
higher positions including administrative positions in public health care 
settings or are associated with private health care setups which in certain 
ways guarantee enough remuneration to maintain their life style. 
Regarding the drug detailing and information, physicians’ largely 
expected that the MSRs should have good knowledge about their drug 
products as well as they must also exhibit good communication skills. 
hese expectations are specially held for newer MSRs who have little 
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Table 3: Summary of personal experience
S.No Social Information Percentage % Sample N
1 Personal Experience of MSR with prescriber
1.1 Prescriber increase drug prescribing for inducements 70.2% 428
1.2 No comments 29.8 % 181
Total 100 % 609
2 Personal experience of prescriber with MSR
2.1
Lack of policies and structure in pharmaceuticals irms 
regarding the issue
92 % 386
2.2 No comments 8 % 34
Total 100 % 420
Table 2: Summary of social information
S.No Social Information Percentage % Sample N
1 Expectation of prescribers
1.1 Good communication skills of drug detailing 12% 50
1.2 Evidence base behind drug being promoted 4.8% 20
1.3 Both 83.2% 350
Total 100% 420
2 Expectation of MSRs
2.1 Prescribers follow ethical practice 67.2 % 409
2.2 Prescribers do not follow ethical practice 32.8 % 200
Total 100 % 609
3 Demands of prescribers from MSRs according to prescribers
3.1 Gits, samples, incentives and inducements 36 % 152
3.2 Continued medical education CME 52.7 % 221
3.3 No demands 11.3 % 47
Total 100 % 420
4 Demands of prescribers from MSRs according to MSRs
4.1 Gits, samples, incentives and inducements 63.8 % 389
4.2 Continued medical education CME 26.2 % 160
4.3 No demands 10 % 60
Total 100 % 609
5 Breakdown of the unethical demands of prescribers Assuming 63.8% as 100%
5.1 Drug samples+leisure trips 67 % 281
5.2 Drug samples+furniture for clinical setting 13 % 55
5.3 Drug samples+personal car 13 % 55
5.4 Drug samples+AC/ LCDs /renovation of the clinical setting 7 % 29
Total 100 % 420
6 Demands of MSRs from prescribers according to MSRs
6.1 Prescribe their brand 99.1% 604
6.2 Do not prescribe competitor’s brand 0.5% 3
6.3 No demands 0.4% 2
Total 100% 420
7 Demands of MSRs from prescribers according to prescribers
7.1 Prescribe their brand 98.2 % 412
7.2 Do not prescribe competitor’s brand 1 % 5
7.3 No demands 0.8 % 3
Total 1 00% 420
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experience in the ield and thus do not have a very sound relationship 
with medical practitioners initially. he medical practitioners, when 
further asked about their demands from the MSRs, they were observed 
to be skeptical initially, however majority (52.7%) of them particularly 
those associated with the private health care setups responded by saying 
that they ask the MSRs for CME in the form of seminars, workshops, 
books, and other materials for information. Moreover, ~36 % of prescribers 
admitted that they demands gits from their respective MSRs. On the 
other side, nearly all the MSRs (99.1%) agreed that they want the doctors 
to prescribe their brand in return. his must be kept in consideration 
that even in the industrialized countries; pharmaceutical manufacturers 
are involved in various kinds of biased practices including apparently 
healthy activities of CMEs where almost ~70% of pharmaceutical com-
panies funding is going in and which also includes tours to resorts and 
leisure trips to expensive places under the name of CME lectures and 
seminars.30 hese practices are now being watched closely by regulatory 
bodies in developed countries and even developing countries are taking 
initiatives to curb them as they are more likely to promote particular 
brands of drugs without enough clinical evidence of it being superior to 
others and even sometime hiding the potential side efects.31-34
On the contrary, when the question was put before the MSRs regarding 
the inducements asked by prescribers and what was their personal 
experience regarding ethical practices, an overwhelming majority 
(70.2%) believed that the prescribers are inluenced by inducements and 
in return the sales of their brands increase. It was further observed that 
out of this majority, a massive percentage (63.8%) of prescribers demand 
unethical inducements like unnecessary drug samples (98.6%), gits 
(54%), leisure trips (67%), clinics’ renovations (33%) and even expensive 
gits like cars (13%). It was also observed that the phenomenon of unethical 
demands from prescribers was directly proportional to their work 
experience and mostly senior ones were found to be boldly asking for 
gits and other inducements. hese views were mainly held by those 
MSRs who had either 5-10 years or more experience as compared to the 
ones who are in the ield for less than 5 years which could be attributed 
to the fact that with the passage of time the sales persons and prescribers 
become accustomed to each other and can communicate easily as 
compared to fresh or young individuals on both sides. hese results are 
in accordance with the study carried out by R. R. Ahmed and T. Jalees in 
2008, where they concluded that these unethical practices were initiated 
by pharmaceutical companies and are now running passively due to 
continuous demands by the medical practitioners.34 It is important to 
consider here that out of all the MSRs interviewed in this study, almost 
25.41% (36.2% out of the initial 70.2% who believed prescribers were 
asking for inducements) considered that medical prescribers did not ask 
for any unethical inducements in their perspective, and only demanded 
for seemingly ethical CMEs in the form of seminars, workshops and lit-
erature etc. Considering the absence of any formal policy from the cen-
tral regulatory body in the country for drug promotion and enormity of 
the prescribers directly asking for gits and other unethical inducements, 
it is still a welcoming igure that at least a signiicant number of practitio-
ners morally do not ask for such clearly unethical favors. It is also worth 
mentioning that majority of prescribers (92%) feel that multinational 
companies are not involved in unethical drug promotion practices and 
it is the national pharmaceutical companies (73.2% believed), owing to 
their largely unregulated drug promotion policies, are indulged in 
unethical means of promotion of their products. his result is also in 
agreement with the previously reported study in Pakistan where 60% of 
the pharmaceutical companies admitted that unethical practices prevail 
in the country and they invest 20-40% of their income in drug marketing 
mainly comprising of CMEs for the prescribers.35 It was also identiied by 
the prescribers in the study that it is the national pharmaceutical 
companies who pursue to achieve their goals without considering any 
form of formal ethics.36,37 his phenomenon is previously reported in 
Pakistan and also similar to India where the national pharma ceutical 
companies are more prone to breach the ethics for promoting their 
pharmaceuticals.38,39
CONCLUSION
his study clariies the current pharmaceutical drug promotion and 
prescribing practices in Pakistan. he majority of prescribers and 
national pharmaceutical irms and to some extent the multinational 
pharmaceuticals are involved in unethical practices in drug promotion 
and prescribing. Alarming policies governing the drug promotion and 
prescribing are required to be implemented by the concerned regulatory 
authorities to avoid unnecessary harm to the patient’s life and pocket 
through the unethical drug promotion. he prescribers should not 
accept any incentives, gits of inancial value from any pharmaceutical 
companies in return for an increase in prescribing selected brand. On 
the other hand, pharmaceutical companies must compete in the market 
on the basis of the drug quality and do not ofer any valuable git and 
incentives to the prescribers. he interaction between doctors and phar-
maceutical irms should be restricted within acceptable boundaries and 
the authorities must be prepared to play an active role. Strengthening the 
regulatory machinery and formulating policies in this regard in neces-
sary. It is essential that a health care professional such as a pharmacist 
can play an important role in this process since he/she is an expert in 
the pharmaceutical ield as well as more aware of the outcomes of unethical 
drug prescribing practices such as polypharmacy and adverse drug 
reactions.
STRENGTHS OF THE STUDY
he study is the irst ever research reported in the context of prescribing 
and promotion practices regarding pharmaceuticals from a developing 
country like Pakistan. he study was conducted all over Pakistan which 
included all 4 provinces and 3 of 4 administrative territories, and 
encompassed a large sample size to ensure data reliability. he study was 
ethically approved.
LIMITATIONS OF THE STUDY
he response rate of the prescribers was low due to sensitivity of issue. 
he prescribers did not have time to ill in their response in the question-
naire therefore, to facilitate the data gathering the survey was conducted 
by interview questionnaire. Most of the questions were close ended; it 
was done due to the fact since, the prescribers had a busy schedule, they 
tend to skip some questions. Nevertheless, the study reported signiicant 
novel indings which outweigh its limitations.
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